Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bjørn Haneberg

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Mucosal Immunity

Living Beings

Disorders

Meningococcal Infections

Anatomy

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
15
Haugen, Inger Lise
14
Holst, Johan
8
Oftung, Fredrik
8
Bakke, Hilde
8
Høiby, Arne
7
Berstad, Aud Katrine Herland
7
Halstensen, A
7
Hordnes, Knut
5
Jonsson, Roland
5
Korsvold, Gro Ellen
5
Dalseg, R
5
Wedege, Elisabeth
4
Aaberge, Ingeborg
4
Janakova, Libuse
3
Michaelsen, Terje

Sign-in to see all Coauthors

Publications

TOP 3
Bakke Hilde; Haneberg Bjørn
[The development of mucosal vaccines]
Bakke H; Samdal H H; Holst J; Oftung F; Haugen I L; Kristoffersen A-C; Haugan A; Janakova L; Korsvold G E; Krogh G; Andersen E A S; Djupesland P; Holand T; Rappuoli R; Haneberg B
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
Bizanov G; Janakova L; Knapstad S-E; Karlstad T; Bakke H; Haugen I L; Haugan A; Samdal H H; Haneberg B
Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bjørn Haneberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2006: Bakke Hilde; Haneberg Bjørn
[The development of mucosal vaccines]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2006;126(21):2818-21.
2006: Bakke H; Samdal H H; Holst J; Oftung F; Haugen I L; Kristoffersen A-C; Haugan A; Janakova L; Korsvold G E; Krogh G; Andersen E A S; Djupesland P; Holand T; Rappuoli R; Haneberg B
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
Scandinavian journal of immunology 2006;63(3):223-31.
2005: Bizanov G; Janakova L; Knapstad S-E; Karlstad T; Bakke H; Haugen I L; Haugan A; Samdal H H; Haneberg B
Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness.
Scandinavian journal of immunology 2005;61(6):503-10.
2005: Samdal Helvi Holm; Bakke Hilde; Oftung Fredrik; Holst Johan; Haugen Inger Lise; Korsvold Gro Ellen; Kristoffersen Anne-Cathrine; Krogh Grethe; Nord Karin; Rappuoli Rino; Berstad Aud Katrine Herland; Haneberg Bjørn
A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvants.
Human vaccines 2005;1(2):85-90.
2004: Bakke Hilde; Setek Torhild N; Huynh Phuong N; Haugen Inger Lise; Høiby E Arne; Holst Johan; Aaberge Ingeborg S; Haneberg Bjørn
Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory.
Vaccine 2004;22(17-18):2278-84.
2003: Haugan Anita; Thi Dao Phuong Xuan; Glende Nina; Bakke Hilde; Haugen Inger Lise; Janakova Libuse; Berstad Aud Katrine Herland; Holst Johan; Haneberg Bjørn
Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccines.
Vaccine 2003;22(1):7-14.
2002: Janakova Libuse; Bakke Hilde; Haugen Inger Lise; Berstad Aud K H; Høiby E Arne; Aaberge Ingeborg S; Haneberg Bjørn
Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines.
Infection and immunity 2002;70(10):5479-84.
2002: Haneberg Bjørn; Holst Johan
Can nonliving nasal vaccines be made to work?
Expert review of vaccines 2002;1(2):227-32.
2001: Haneberg B; Herland Berstad A K; Holst J
Bacteria-derived particles as adjuvants for non-replicating nasal vaccines.
Advanced drug delivery reviews 2001;51(1-3):143-7.
2001: Bakke H; Lie K; Haugen I L; Korsvold G E; Høiby E A; Naess L M; Holst J; Aaberge I S; Oftung F; Haneberg B
Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance.
Infection and immunity 2001;69(8):5010-5.
2000: Grewal H M; Karlsen T H; Vetvik H; Ahrén C; Gjessing H K; Sommerfelt H; Haneberg B
Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses.
Journal of immunological methods 2000;239(1-2):53-62.
2000: Berstad A K; Oftung F; Korsvold G E; Haugen I L; Froholm L O; Holst J; Haneberg B
Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine.
Vaccine 2000;18(22):2323-30.
2000: Berstad A K; Andersen S R; Dalseg R; Dromtorp S; Holst J; Namork E; Wedege E; Haneberg B
Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine.
Vaccine 2000;18(18):1910-9.
2000: Berstad A K; Holst J; Frøholm L O; Haugen I L; Wedege E; Oftung F; Haneberg B
A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.
Journal of medical microbiology 2000;49(2):157-63.
1999: Johansen F E; Pekna M; Norderhaug I N; Haneberg B; Hietala M A; Krajci P; Betsholtz C; Brandtzaeg P
Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice.
The Journal of experimental medicine 1999;190(7):915-22.
1999: Hvalbye B K; Aaberge I S; Løvik M; Haneberg B
Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
Infection and immunity 1999;67(9):4320-5.
1999: Dalseg R; Wedege E; Holst J; Haugen I L; Høiby E A; Haneberg B
Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice.
Vaccine 1999;17(19):2336-45.
1999: Oftung F; Naess L M; Wetzler L M; Korsvold G E; Aase A; Høiby E A; Dalseg R; Holst J; Michaelsen T E; Haneberg B
Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine.
Infection and immunity 1999;67(2):921-7.
1998: Hordnes K; Trovik J; Tynning T; Haneberg B
Self-sampled and air-dried cervicovaginal secretions can be used for analyses of mucosal antibodies.
Journal of immunological methods 1998;220(1-2):151-9.
1998: Vetvik H; Grewal H M; Haugen I L; Ahrén C; Haneberg B
Mucosal antibodies can be measured in air-dried samples of saliva and feces.
Journal of immunological methods 1998;215(1-2):163-72.
1998: Haneberg B; Dalseg R; Wedege E; Høiby E A; Haugen I L; Oftung F; Andersen S R; Naess L M; Aase A; Michaelsen T E; Holst J
Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.
Infection and immunity 1998;66(4):1334-41.
1998: Hordnes K; Tynning T; Kvam A I; Bevanger L; Brown T A; Jonsson R; Haneberg B
Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Scandinavian journal of immunology 1998;47(2):179-88.
1998: Haneberg B; Dalseg R; Oftung F; Wedege E; Høiby E A; Haugen I L; Holst J; Andersen S R; Aase A; Meyer Naess L; Michaelsen T E; Namork E; Haaheim L R
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.
Developments in biological standardization 1998;92():127-33.
1997: Hordnes K; Jonsson R; Brandtzaeg P; Haneberg B
[What is the purpose of mucosal antibodies? Relevance to colonization with group B streptococci]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(28):4109-13.
1997: Berstad A K; Holst J; Møgster B; Haugen I L; Haneberg B
A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin.
Vaccine 1997;15(12-13):1473-8.
1997: Hordnes K; Tynning T; Brown T A; Haneberg B; Jonsson R
Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice.
Vaccine 1997;15(11):1244-51.
1996: Hordnes K; Tynning T; Kvam A I; Jonsson R; Haneberg B
Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women.
Infection and immunity 1996;64(5):1643-52.
1995: Hordnes K; Eide M; Ulstein M; Digranes A; Haneberg B
Evaluation of a rapid enzyme immunoassay for detection of genital colonization of group B streptococci in pregnant women: own experience and review.
The Australian & New Zealand journal of obstetrics & gynaecology 1995;35(3):251-3.
1995: Hordnes K; Digranes A; Haugen I L; Helland D E; Ulstein M; Jonsson R; Haneberg B
Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa.
Journal of reproductive immunology 1995;28(3):247-62.
1987: Haneberg B; Sørnes S; Bakke O; Solberg C O
Inhibition of in vitro lysozyme release from human granulocytes and monocytes by non-steroidal anti-inflammatory agents.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 1987;95(4):149-53.
1987: Pedersen S H; Haneberg B; Halstensen A; Solberg C O
[Mortality in meningococcal disease. Relation to time of hospitalization]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1987;107(22):1739-40.
1987: Halstensen A; Solberg C O; Pedersen S H; Haneberg B
[Mortality in meningococcal disease. Relation to age, sex and clinical signs]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1987;107(22):1735-8.
1987: Halstensen A; Haneberg B
Standardization of a chemiluminescence method for the measurement of meningococcal opsonins using ethanol fixed meningococci.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 1987;95(4):155-60.
1987: Halstensen A; Vollset S E; Haneberg B; Høiby E A; Solberg C O
Antimicrobial therapy and case fatality in meningococcal disease.
Scandinavian journal of infectious diseases 1987;19(4):403-7.
1987: Halstensen A; Pedersen S H; Haneberg B; Bjorvatn B; Solberg C O
Case fatality of meningococcal disease in western Norway.
Scandinavian journal of infectious diseases 1987;19(1):35-42.
1986: Halstensen A; Haneberg B; Glette J; Sandberg S; Solberg C O
Factors important for the measurement of chemiluminescence production by polymorphonuclear leukocytes.
Journal of immunological methods 1986;88(1):121-8.
1984: Halstensen A; Haneberg B; Frøholm L O; Lehmann V; Frasch C E; Solberg C O
Human opsonins to meningococci after vaccination.
Infection and immunity 1984;46(3):673-6.
1984: Kalager T; Haneberg B; Glette J; Søndenaa K; Sørnes S; Solberg C O
The influence of harvesting intervals on chemiluminescence and enzyme activities of rat peritoneal leukocytes.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 1984;92(5):301-5.
1980: Haneberg B; Bertnes E; Ulstein M
Mitogen-induced multiplication of lymphocytes from newborn infants.
European journal of pediatrics 1980;134(1):23-6.
1980: Bertnes E; Haneberg B; Bakke O M
[Digoxin treatment of the newborn]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1980;100(4):208-9.

Sign-in to see more